Castelló d’Empúries, Girona – June 2025 – Skin Tech Pharma Group, a leading company specialized in the production and distribution of aesthetic medical solutions, has been honoured with the “Premi a la Pime més competitiva” (Most Competitive SME Award) in the Medium-Sized Company category.
This recognition highlights a landmark year for the company, marked by the successful international expansion of its flagship product RRS® HA Long Lasting—a breakthrough injectable medical device that introduces a new category in aesthetic medicine: the Skin Builder. Developed to regenerate, strengthen, and rejuvenate the skin with natural and clinically proven results, the product combines cross-linked hyaluronic acid with 15 specific amino acids, offering a pioneering solution endorsed by medical professionals worldwide.
In 2024, the company significantly expanded its global footprint and plans to strengthen its international reach further by opening new commercial branches in Spain and China in 2025.
To support this growth, Skin Tech Pharma Group will soon inaugurate a new 6,000 m² state-of-the-art production facility, designed to enhance manufacturing capacity while upholding the highest standards of quality, innovation, and local production.
Additionally, the company is experiencing strong financial momentum, with the strategic entry of its reference investment partner Charterhouse into its capital structure in June 2024. This milestone validates the company’s vision and will further accelerate investments in R&D, innovation, and global expansion.
The award was received by Marcio Rodrigues, CEO of Skin Tech Pharma Group, and presented by the President of the Generalitat, Salvador Illa.
